Literature DB >> 1275357

Therapy of Staphylococcus aureus bacteremia associated with a removable focus of infection.

P B Iannini, K Crossley.   

Abstract

We did a retrospective study of Staphylococcus aureus bacteremia--from removable foci of infection--treated with short course antimicrobial therapy. Patients with S. aureus endocarditis were excluded from our study. The majority of patients had sepsis from intravascular devices. After removal of the focus of bacteremia, antibiotics were administered for a mean period of 15.2 days. There were no relapses, and no patient developed endocarditis. A 10- to 21-day antibiotic regimen can be curative in S. aureus bacteremia associated with a removable focus of infection.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 1275357     DOI: 10.7326/0003-4819-84-5-558

Source DB:  PubMed          Journal:  Ann Intern Med        ISSN: 0003-4819            Impact factor:   25.391


  14 in total

1.  [In vitro studies on human ovarian contractility (author's transl)].

Authors:  H Okamura; T Okazaki; A Nakajima
Journal:  Nihon Funin Gakkai Zasshi       Date:  1975-10

2.  Audit of treatment of Staphylococcus aureus bacteraemia.

Authors:  V Wong; R Wariyar; V Weston; W J Olver; E Youngs; A Hussain; N Perera; A Swann
Journal:  Clin Med (Lond)       Date:  2010-06       Impact factor: 2.659

3.  Clinical practice guidelines for the diagnosis and management of intravascular catheter-related infection: 2009 Update by the Infectious Diseases Society of America.

Authors:  Leonard A Mermel; Michael Allon; Emilio Bouza; Donald E Craven; Patricia Flynn; Naomi P O'Grady; Issam I Raad; Bart J A Rijnders; Robert J Sherertz; David K Warren
Journal:  Clin Infect Dis       Date:  2009-07-01       Impact factor: 9.079

4.  Treatment duration for uncomplicated Staphylococcus aureus bacteremia to prevent relapse: analysis of a prospective observational cohort study.

Authors:  Yong Pil Chong; Song Mi Moon; Kyung-Mi Bang; Hyun Jung Park; So-Youn Park; Mi-Na Kim; Ki-Ho Park; Sung-Han Kim; Sang-Oh Lee; Sang-Ho Choi; Jin-Yong Jeong; Jun Hee Woo; Yang Soo Kim
Journal:  Antimicrob Agents Chemother       Date:  2012-12-17       Impact factor: 5.191

5.  Effect of Algorithm-Based Therapy vs Usual Care on Clinical Success and Serious Adverse Events in Patients with Staphylococcal Bacteremia: A Randomized Clinical Trial.

Authors:  Thomas L Holland; Issam Raad; Helen W Boucher; Deverick J Anderson; Sara E Cosgrove; P Suzanne Aycock; John W Baddley; Anne-Marie Chaftari; Shein-Chung Chow; Vivian H Chu; Manuela Carugati; Paul Cook; G Ralph Corey; Anna Lisa Crowley; Jennifer Daly; Jiezhun Gu; Ray Hachem; James Horton; Timothy C Jenkins; Donald Levine; Jose M Miro; Juan M Pericas; Paul Riska; Zachary Rubin; Mark E Rupp; John Schrank; Matthew Sims; Dannah Wray; Marcus Zervos; Vance G Fowler
Journal:  JAMA       Date:  2018-09-25       Impact factor: 56.272

6.  Efficacy of dicloxacillin-coated polyurethane catheters in preventing subcutaneous Staphylococcus aureus infection in mice.

Authors:  R J Sherertz; D M Forman; D D Solomon
Journal:  Antimicrob Agents Chemother       Date:  1989-08       Impact factor: 5.191

Review 7.  Optimum treatment of staphylococcal infections.

Authors:  J Turnidge; M L Grayson
Journal:  Drugs       Date:  1993-03       Impact factor: 9.546

8.  Infectious Disease Consultation for Staphylococcus aureus Bacteremia Improves Patient Management and Outcomes.

Authors:  Alexa A Pragman; Michael A Kuskowski; James M Abraham; Gregory A Filice
Journal:  Infect Dis Clin Pract (Baltim Md)       Date:  2012-07-01

9.  Serious complications of vascular catheter-related Staphylococcus aureus bacteremia in cancer patients.

Authors:  I Raad; J Narro; A Khan; J Tarrand; S Vartivarian; G P Bodey
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1992-08       Impact factor: 3.267

10.  Clinical value of teichoic acid antibody titers in the diagnosis and management of the staphylococcemias.

Authors:  A S Bayer; D B Tillman; N Concepcion; L B Guze
Journal:  West J Med       Date:  1980-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.